Literature DB >> 21082441

An integrated top-down and bottom-up strategy for characterization of protein isoforms and modifications.

Si Wu1, Nikola Tolić, Zhixin Tian, Errol W Robinson, Ljiljana Paša-Tolić.   

Abstract

Bottom-up and top-down strategies are two commonly used methods for mass spectrometry (MS) based protein identification; each method has its own advantages and disadvantages. In this chapter, we describe an integrated top-down and bottom-up approach facilitated by concurrent liquid chromatography-mass spectrometry (LC-MS) analysis and fraction collection for comprehensive high-throughput intact protein profiling. The approach employs a high resolution reversed phase (RP) LC separation coupled with LC eluent fraction collection and concurrent on-line MS with a high field (12 T) Fourier-transform ion cyclotron resonance (FTICR) mass spectrometer. Protein elusion profiles and tentative modified protein identification are made using detected intact protein mass in conjunction with bottom-up protein identifications from the enzymatic digestion and analysis of corresponding LC fractions. Specific proteins of biological interest are incorporated into a target ion list for subsequent off-line gas-phase fragmentation that uses an aliquot of the original collected LC fraction, an aliquot of which was also used for bottom-up analysis.

Mesh:

Substances:

Year:  2011        PMID: 21082441     DOI: 10.1007/978-1-60761-977-2_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Drug metabolite profiling and identification by high-resolution mass spectrometry.

Authors:  Mingshe Zhu; Haiying Zhang; W Griffith Humphreys
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Top-down Mass Spectrometry Analysis of Human Serum Autoantibody Antigen-Binding Fragments.

Authors:  Zhe Wang; Xiaowen Liu; Jennifer Muther; Judith A James; Kenneth Smith; Si Wu
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.